Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

NCT07077512 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Large B Cell Diffuse Lymphoma
Mantle Cell Lymphoma (MCL)
Follicular Lymphoma ( FL)

Interventions

DRUG: Autoleucel (Relmacabtagene Autoleucel)
DRUG: Sintilimab (PD-1 inhibitor)

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]